ExecPay

John Sharp

Overview20182017

Overview

John Sharp received an average of $417K in total compensation, including $313K in salary, at PhaseBio Pharmaceuticals between 2017 and 2018.

Source: SEC filing on April 5, 2019.
Sharp's 2018 pay

Related executives

We found three more executives who work or worked at PhaseBio Pharmaceuticals.

Jonathan Mow

PhaseBio Pharmaceuticals

Chief Executive Officer

5

John Lee

PhaseBio Pharmaceuticals

Chief Medical Officer

5

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

4

News

You may also like

PhaseBio Pharmaceuticals